Your browser doesn't support javascript.
loading
Response rates to single-agent chemotherapy after exposure to immune checkpoint inhibitors in advanced non-small cell lung cancer.
Schvartsman, Gustavo; Peng, S Andrew; Bis, Giorgios; Lee, J Jack; Benveniste, Marcelo F K; Zhang, Jianjun; Roarty, Emily B; Lacerda, Lara; Swisher, Stephen; Heymach, John V; Fossella, Frank V; William, William N.
Afiliação
  • Schvartsman G; Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, 1400 Holcombe Blvd, Unit 463., Houston, TX, 77030, USA. Electronic address: gustavoschv@gmail.com.
  • Peng SA; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Houston, TX, 77030, USA. Electronic address: speng1@mdanderson.org.
  • Bis G; Department of Radiology, Baylor College of Medicine, 6620 Main St, 12th Floor, Suite 1275, Houston, TX, 77030, USA. Electronic address: bis@bcm.edu.
  • Lee JJ; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Houston, TX, 77030, USA. Electronic address: jjlee@mdanderson.org.
  • Benveniste MFK; Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center. 1515 Holcombe Blvd, Room 1478, Houston, TX, 77030, USA. Electronic address: mfbenveniste@mdanderson.org.
  • Zhang J; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 432, Houston, TX, 77030, USA. Electronic address: jzhang20@mdanderson.org.
  • Roarty EB; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 432, Houston, TX, 77030, USA. Electronic address: ecbrantley@mdanderson.org.
  • Lacerda L; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 432, Houston, TX, 77030, USA. Electronic address: LCAlvarez@mdanderson.org.
  • Swisher S; Department of Thoracic and Cardiovascular Surgery, Division of Surgery, The University of Texas MD Anderson Cancer Center, 1400 Pressler St., Houston, TX, 77030, USA. Electronic address: sswisher@mdanderson.org.
  • Heymach JV; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 432, Houston, TX, 77030, USA. Electronic address: jheymach@mdanderson.org.
  • Fossella FV; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 432, Houston, TX, 77030, USA. Electronic address: ffossell@mdanderson.org.
  • William WN; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 432, Houston, TX, 77030, USA. Electronic address: wnwillia@mdanderson.org.
Lung Cancer ; 112: 90-95, 2017 10.
Article em En | MEDLINE | ID: mdl-29191606
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Antineoplásicos Imunológicos / Neoplasias Pulmonares Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Antineoplásicos Imunológicos / Neoplasias Pulmonares Idioma: En Ano de publicação: 2017 Tipo de documento: Article